Loading...

FITC anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
104_FITC_090507
C57BL/6 mouse splenocytes stained with 104 FITC
  • 104_FITC_090507
    C57BL/6 mouse splenocytes stained with 104 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
109805 50 µg £37
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109806 500 µg £80
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3. 

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed
  2. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  3. He D, et al. 2022. Immunity. 55:159. PubMed
  4. Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed
  5. Wang D, et al. 2022. Cell Rep. 39:110587. PubMed
  6. Jiang W, et al. 2022. Redox Biol. 56:102432. PubMed
  7. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  8. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  9. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  10. Rundberg Nilsson A, et al. 2023. iScience. 26:106341. PubMed
  11. Coelho DR, et al. 2023. iScience. 26:106442. PubMed
  12. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  13. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  14. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  15. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  16. Michalova J, et al. 2011. Biol Blood Marrow Transplant. 17:1273. PubMed
  17. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  18. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  19. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  20. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  21. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  22. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  23. Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
  24. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  25. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  26. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  27. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  28. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  29. Burman A, et al. 2007. Blood. 110:1064. PubMed
  30. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  31. Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed
  32. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  33. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  34. Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed
  35. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  36. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  37. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  38. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  39. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  40. Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
  41. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  42. Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed
  43. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  44. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  45. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  46. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  47. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  48. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  49. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  50. Li J, et al. 2020. Elife. 9:00. PubMed
  51. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  52. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  53. Wan X, et al. 2018. Nature. 560:107. PubMed
  54. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  55. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  56. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  57. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  58. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  59. Abbott RK, et al. 2018. Immunity. 48:133. PubMed
  60. Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
  61. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  62. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  63. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  64. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  65. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  66. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  67. Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
  68. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  69. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  70. Zhang W, et al. 2022. Nat Methods. 19:759. PubMed
  71. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  72. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  73. Burgess M, et al. 2014. Blood. 124:3947. PubMed
  74. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  75. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  76. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  77. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  78. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  79. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  80. de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
  81. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  82. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  83. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  84. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  85. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  86. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  87. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  88. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  89. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  90. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  91. Koide S, et al. 2022. iScience. 25:103603. PubMed
  92. Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed
  93. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  94. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  95. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  96. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  97. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  98. Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
  99. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  100. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  101. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  102. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  103. Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
  104. Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed
  105. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  106. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  107. Hung LY, et al. 2019. J Immunol. 203:511. PubMed
  108. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  109. Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
  110. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  111. Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
  112. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  113. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  114. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
RRID
AB_313442 (BioLegend Cat. No. 109805)
AB_313443 (BioLegend Cat. No. 109806)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45.2 Reagents Request Custom Conjugation
Description Clone Applications
Biotin anti-mouse CD45.2 104 FC
FITC anti-mouse CD45.2 104 FC
PE anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 104 FC,Block,IHC-F,IP
APC anti-mouse CD45.2 104 FC
Alexa Fluor® 488 anti-mouse CD45.2 104 FC
Alexa Fluor® 647 anti-mouse CD45.2 104 FC
Pacific Blue™ anti-mouse CD45.2 104 FC
Alexa Fluor® 700 anti-mouse CD45.2 104 FC
APC/Cyanine7 anti-mouse CD45.2 104 FC
PerCP anti-mouse CD45.2 104 FC
PerCP/Cyanine5.5 anti-mouse CD45.2 104 FC
PE/Cyanine7 anti-mouse CD45.2 104 FC
Brilliant Violet 421™ anti-mouse CD45.2 104 FC
Brilliant Violet 570™ anti-mouse CD45.2 104 FC
Brilliant Violet 650™ anti-mouse CD45.2 104 FC
Brilliant Violet 510™ anti-mouse CD45.2 104 FC
Brilliant Violet 785™ anti-mouse CD45.2 104 FC
Brilliant Violet 605™ anti-mouse CD45.2 104 FC
Purified anti-mouse CD45.2 (Maxpar® Ready) 104 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45.2 104 FC
Brilliant Violet 711™ anti-mouse CD45.2 104 FC
Alexa Fluor® 594 anti-mouse CD45.2 104 IHC-F,SB
APC/Fire™ 750 anti-mouse CD45.2 104 FC
TotalSeq™-A0157 anti-mouse CD45.2 104 PG
TotalSeq™-B0157 anti-mouse CD45.2 104 PG
TotalSeq™-C0157 anti-mouse CD45.2 104 PG
Brilliant Violet 750™ anti-mouse CD45.2 104 FC
Spark Blue™ 550 anti-mouse CD45.2 104 FC
Spark NIR™ 685 anti-mouse CD45.2 104 FC
Spark UV™ 387 anti-mouse CD45.2 104 FC
Spark Blue™ 574 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Spark Red™ 718 anti-mouse CD45.2 (Flexi-Fluor™) 104 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account